Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New research shows that treating these viruses can reduce liver cancer risk.
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
All people ages 18 to 79 should be screened for hepatitis C virus at least once, regardless of risk factors.
Study results underline the importance of treating hepatitis C virus.
All adults in this age range should be screen for hepatitis C.
Successful treatment with direct-acting antivirals prolonged survival by 18 months.
Those diagnosed with liver cancer after an HCV cure had a 66% lower risk of death.
People who received the vaccine did, however, show stronger immune responses against the virus.
Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.
Two new interactive (and free!) databases offer maps, policies and much more, courtesy of amfAR.
Wider screening would prevent liver cirrhosis, liver cancer and the need for liver transplants.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
Karen Hoyt promised her grandkids she would win a gold medal in the World Transplant Games. She wasn’t going to let HCC stand in her way.
Help find the “missing millions” who don’t know they’re living with viral hepatitis.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.